1. Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G)

   Klaassen, S. H. C., Lemmink, H. H., Bijzet, J., Glaudemans, A. W. J. M., Bos, R., Plattel, W., van den Berg, M. P., Slart, R. H. J. A., Nienhuis, H. L. A., van Veldhuisen, D. J. & Hazenberg, B. P. C., Aug-2017, In : Cardiovascular Pathology. 29, p. 19-22 4 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Mid-treatment TARC and mid-treatment FGD-PET predict for progression free survival in classical hodgkin lymphom

   Plattel, W. J., Berg, van den, A., Visser, L., Glaudemans, A., Diepstra, A. & van Imhoff, G., 20-Oct-2016, In : Haematologica. 101, p. 31-31 1 p., T014.

   Research output: Contribution to journal › Meeting Abstract › Academic

3. Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC

   Plattel, W. J., Alsada, Z. N. D., van Imhoff, G. W., Diepstra, A., van den Berg, A. & Visser, L., Dec-2016, In : British Journal of Haematology. 175, 5, p. 868-875 8 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Insulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphoma

   Liang, Z., Diepstra, A., Xu, C., van Imhoff, G., Plattel, W., Van Den Berg, A. & Visser, L., 28-Jan-2014, In : PLoS ONE. 9, 1, 9 p., e87474.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphoma

   Xu, C., Plattel, W., van den Berg, A., Ruether, N., Huang, X., Wang, M., de Jong, D., Vos, H., van Imhoff, G., Viardot, A., Moeller, P., Poppema, S., Diepstra, A. & Visser, L., Apr-2012, In : Haematologica. 97, 4, p. 572-578 7 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (7) »